If a drug has the suffix 'deconoate', what does it indicate about the medication?

The suffix 'deconoate' in a medication indicates that it is a long-acting injectable form, typically administered intramuscularly. This formulation is often used to manage conditions where patient compliance is a concern, such as in the treatment of schizophrenia or bipolar disorder. The extended-release nature allows for less frequent dosing, which is beneficial for patients who may struggle with taking medications daily. By providing a steady release of medication over time, it can help maintain therapeutic levels in the bloodstream, reducing the risk of relapse or exacerbation of symptoms due to noncompliance. The other options do not accurately reflect the characteristics associated with drugs that have the 'deconoate' suffix.